elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Chronic lymphocytic leukemia
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Chronic lymphocytic leukemia
RIS
0.001
(Research Intensity Score)
Papers
253
Top papers
Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
2022 · 239 citations
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
2019 · 743 citations
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
2019 · 179 citations
The cure of leukemia through the optimist's prism
2021 · 67 citations
The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
2025 · 9 citations
Pirtobrutinib in Chronic Lymphocytic Leukemia: Navigating Resistance and the Personalisation of BTK-Targeted Therapy
2025 · 5 citations
Bruton Tyrosine Kinase Degraders
2025 · 8 citations
Sequential versus Simultaneous Quantitative Analysis of Biomarkers in Individual Cells by ICP-MS and Mass Cytometry: A Focus on Immunotherapy
2025 · 3 citations
The significance of galectin-9 and T-cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3) in patients with chronic lymphocytic leukemia: The role of immune evasion
2026
Newest papers
The significance of galectin-9 and T-cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3) in patients with chronic lymphocytic leukemia: The role of immune evasion
2026
Late-Onset Episodic Weakness With Hyperkalemia Suggestive of Hyperkalemic Periodic Paralysis
2026
CD37 is a promising molecular target for CAR-T cells in chronic lymphocytic leukemia
2026
Therapeutic potential of antisense oligonucleotides in hematological malignancies
2026
Radiometabolic Therapy in Lymphoma: From Radioimmunotherapy to Emerging Theranostic and Combination Strategies
2026
The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
2025 · 9 citations
Pirtobrutinib in Chronic Lymphocytic Leukemia: Navigating Resistance and the Personalisation of BTK-Targeted Therapy
2025 · 5 citations
Bruton Tyrosine Kinase Degraders
2025 · 8 citations
Sequential versus Simultaneous Quantitative Analysis of Biomarkers in Individual Cells by ICP-MS and Mass Cytometry: A Focus on Immunotherapy
2025 · 3 citations
Browse all papers →
Chronic lymphocytic leukemia's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Chronic lymphocytic leukemia's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link